DLA Piper LLP (US)
4365 Executive Drive, Suite 1100
San Diego, CA 92121-2189
O] 858-677-1476
F] 858-677-1401
August 14, 2009
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention:
|
|
Larry Spirgel |
|
|
Assistant Director |
|
|
|
Re:
|
|
Qualcomm Incorporated |
|
|
Form 10-Q for the Quarterly Period Ended March 29, 2009 |
|
|
File No. 0-19528 |
Dear Mr. Spirgel:
On behalf of Qualcomm Incorporated (Qualcomm or the Company), I am writing in response to the
comments contained in your letter dated July 15, 2009 (the Comment Letter) regarding Qualcomms
Form 10-Q for the quarterly period ended March 29, 2009.
I enclose herewith copies of the Agreement (as defined below) and the Duff & Phelps report
(collectively, the Confidential Material). The Confidential Material is marked Confidential
Treatment Requested by Qualcomm Incorporated and is identified
with numbers 0001 through 0302.
Pursuant to Rule 12b-4 promulgated under the Securities Exchange Act of 1934, as amended, the
Confidential Material is being provided to the Staff on a confidential, supplemental basis only and
is not to be filed with or deemed part of the 10-Q. Pursuant to Rule 12b-4, I hereby request on
behalf of Qualcomm that the Confidential Material be returned to me promptly following completion
of the Staffs review. Please contact me when you have completed your review, and I will arrange to
have the Confidential Material retrieved from the Commission.
On behalf of Qualcomm, I hereby request pursuant to Rule 83 of the Commissions Rules of Practice
confidential treatment for (i) the entirety of the Confidential Material and (ii) the redacted
portions of this response letter, which are indicated herein as [***]. Please promptly inform me of
any request for disclosure of all or a portion of such material made pursuant to the Freedom of
Information Act or otherwise, so that the Company may substantiate the foregoing request for
confidential treatment in accordance with Rule 83.
Mr. Larry Spirgel
August 14, 2009
Page 2
A copy of this request (but not the Confidential Material) is also being delivered to the Freedom
of Information Act Officer of the Commission.
Overview
Before addressing each of the Staffs comments, the Company believes it is useful to provide a high
level overview of its litigation with Broadcom Corporation (Broadcom) prior to the execution of
the Settlement and Patent License and Non-Assert Agreement, dated April 26, 2009 (the Agreement).
Since 2005, the Company and Broadcom had been engaged in a series of complex legal disputes in
various forums. As discussed in the Companys response to comment #5 below, these litigation events
and the risks associated with loss of customers, litigation losses and injunctions were described
in the Companys reports filed under the Exchange Act. As time progressed, the litigation matters
(and adverse rulings in many of them) were increasingly creating significant uncertainties, risks and burdens for the Company, including
ongoing legal expenses of approximately [***]. (See listing
of litigation matters below.) [***]
While the discussion that follows is long and complex, the simple fact is that the Company did not
believe that rights to Broadcoms patents was of significant value compared to the overall value of
the settlement. The decision to settle the litigation for the amount agreed upon was driven
primarily by other factors relating to the breadth and scope of the dispute [***].
Broadcom asserted nearly 20 patents against the Company. Most of the asserted patents were part of
a portfolio that Broadcom acquired in 2002 for approximately $24 million. (The same portfolio had
been offered to the Company previously for a similar price, and after evaluating the portfolio, the
Company declined to purchase it.) Of the nearly 20 patents Broadcom asserted, it prevailed at trial
on only four (and of those, only two ultimately survived appeal). As to the four patents on which
Broadcom initially prevailed, the Company successfully prepared and deployed technical design
arounds (i.e., technical modifications, such as redesigns of the hardware or implementation of new
software, to change the structure or function accused of infringing) for its products on all of the
claims it was found to have infringed. In addition, at the time of the settlement, one patent
remained to be tried (scheduled for trial in September). With respect to that patent, the U.S.
Patent and Trademark Office (USPTO), based on the Companys submissions, recently found all the
asserted claims to be invalid. These facts underlie the Companys conclusion that rights to
Broadcoms patents were of insignificant value compared to the overall value of the settlement.
Despite the fact that Broadcoms standing success on the patent claims had been reduced to two
patents, a significant consideration developed in early 2009 in the Central District of California
patent case (the 467 case). That consideration was the combination of the
Mr. Larry Spirgel
August 14, 2009
Page 3
district courts increasingly expansive view of the scope of the injunction and a setback regarding the timing of
appellate review, both of which amplified risks and uncertainties to the Companys ongoing business
and commercial relationships that needed to be resolved. Part of the injunction issued by the
federal court in California was directed to a portion of the Companys third generation (3G) CDMA
chipsets. While the Company had succeeded in developing and deploying a design around that brought
the products outside of the scope of the patent claims, over a series of motions resulting in
adverse rulings, the court adopted an increasingly expansive view of its authority to enjoin the
Companys activities, eventually indicating that it had the authority to enjoin even noninfringing
activities. While the Company vehemently disagreed with the courts interpretation of its
authority, the Companys efforts to obtain expedited and timely appellate review failed. The denial
of expedited appellate review meant that the Companys important redesigns would be evaluated in a
context of the district courts expansive interpretation of its powers to enjoin without the likely
prospect of a timely appellate relief if needed. Given this circumstance, the potential for
substantially increased disruption to the Companys business and damage to its commercial
relationships mounted. Even if the Company ultimately prevailed on appeal with respect to the
proper interpretation of the injunction and the effectiveness of the design arounds, which it
certainly believed it would, a delayed victory could have been a pyrrhic victory if the district
court rulings resulted in damage to the Company and its commercial relationships in the interim.
These considerations were, in the Companys view, separate and apart from the value of the patent
rights.
While the Company previously had successfully defended an equally significant design around in
another case (the International Trade Commission, ITC, matter) [***]. At the time the litigation
over the injunction in district court evolved to this stage, and the appellate court denied the
motion for expedited review, and in light of the many other considerations and circumstances
relating to the overall dispute as described in this response, the Company decided to move forward
with this settlement even though the amount paid [***].
As is apparent from the following listing of U.S.-based litigation and foreign regulatory agency
complaints between 2005 and 2009, the array of disputes between the Company and Broadcom was
extensive. Throughout the lengthy term of the disputes, Broadcom was attempting to but had never
participated significantly in the cellular industry as a supplier of baseband chipsets, the primary
components in wireless handsets (i.e., cell phones). The Company, on the other hand, had extensive
and well-established relationships with virtually all of the handset manufacturers and carriers providing products and services in the
United States (e.g., Motorola, Samsung, LGE, Verizon and Sprint). [***] Despite the Companys belief that it would ultimately prevail through the courts
on remaining issues, [***], with critical developments occurring in early 2009 that drove the ultimate push
to settlement.
Mr. Larry Spirgel
August 14, 2009
Page 4
From the inception of the litigation by Broadcom in May 2005, the following matters were in dispute
between the two companies:
|
- |
|
467 (commenced May 18, 2005): Broadcom patent infringement against Qualcomm;
Central District of California. |
|
|
|
Litigated through trial and appeal on three patents;
post-verdict injunction issues and related appeals were still pending as of
the date of settlement. |
|
|
|
|
Fourth patent (051) in litigation and scheduled for trial as
of the date of settlement. |
|
- |
|
468 (commenced May 18, 2005): Broadcom patent infringement against Qualcomm;
Central District of California. |
|
|
|
Stayed pending the outcome of the U.S. International Trade
Commission matter on same three patents as in the ITC matter; still pending as
of the date of settlement. |
|
- |
|
ITC (commenced May 19, 2005): Broadcom patent infringement against Qualcomm;
U.S. International Trade Commission. |
|
|
|
Same patents at issue in 468; litigated through final
decision, appealed, remanded for further proceedings as of the date of
settlement; |
|
|
|
|
Enforcement action filed on exclusion order; pending final
decision as of the date of settlement. |
|
- |
|
3350/1607 (commenced July 1, 2005): Broadcom antitrust claims against
Qualcomm; filed in New Jersey District Court and transferred to Southern District of
California. |
|
|
|
Litigated through dismissal, appeal and remand in New Jersey
prior to transfer to San Diego; still pending (discovery ongoing) as of the
date of settlement. |
|
- |
|
1829 (commenced October 7, 2008): Broadcom patent exhaustion claims against
Qualcomm; Southern District of California. |
|
|
|
Still pending as of the date of settlement. |
|
- |
|
1392 (commenced July 11, 2005): Cross claims for patent infringement;
Southern District of California. |
|
|
|
Dismissed prior to the date of settlement. |
|
- |
|
1662 (commenced August 24, 2005): Cross claims for trade secret
misappropriation and patent infringement; Southern District of California. |
|
|
|
Dismissed prior to the date of settlement. |
|
- |
|
1958 (commenced October 14, 2005): Qualcomm patent infringement against
Broadcom; Southern District of California. |
|
|
|
Litigated through trial and appeal; ancillary matters still
pending as of the date of settlement. |
|
- |
|
0660 (commenced March 24, 2006): Broadcom patent infringement against
Qualcomm; Southern District of California. |
|
|
|
Patent removed/transferred from other cases; dismissed prior
to the date of settlement. |
Mr. Larry Spirgel
August 14, 2009
Page 5
|
- |
|
1249 (commenced April 12, 2007): Broadcom unfair competition against
Qualcomm; California State Court, Orange County. |
|
|
|
Still pending as of the date of settlement. |
|
- |
|
Commission of The European Communities Directorate-General Competition
(Complaint filed October 26, 2005): |
|
|
|
Broadcom unfair competition complaint against Qualcomm |
|
- |
|
Korea Fair Trade Commission (Investigation initiated February 26, 2006): |
|
|
|
Broadcom unfair competition complaint against Qualcomm |
While all of the disputes listed above contributed to the cumulative burden of the litigation on
the Company and the cellular industry, the post-judgment disputes in the ITC and 467 matters stand
out. On June 7, 2007, the ITC issued an exclusion order and a cease and desist order against
certain of the Companys chipsets and excluded from importation downstream products (handsets)
containing the affected chipsets. These remedial orders were based on a finding of infringement of
one set of claims of one patent at issue (the 983 patent). The ITC issued its downstream exclusion
order, broadly impacting cellular handsets imported into the United States, despite significant
involvement and opposition from many handset manufacturers and carriers in the wireless industry
protesting against a downstream remedy. The United States Court of Appeals for the Federal Circuit
eventually stayed the exclusion order as it applied to downstream products, and then reversed the
infringement finding and determined that the downstream remedy was unlawful. As a result of the
ITCs order, however, the Company had engaged in an extensive effort to develop, test and deploy a
design around for use in its products to avoid the infringement as determined by the ITC and to
avoid any harm to the industry as a result of the remedial orders. This was the first of several
design arounds developed and deployed by the Company in the course of the overall dispute with
Broadcom. After a significant amount of effort, the design around was widely accepted by the
Companys customers and carriers [***]. The design around was quickly challenged by Broadcom through an
enforcement action filed in the ITC, which was heard in April 2008. Following a three-day hearing
in which the new design was successfully defended, the administrative law judge took no action on
Broadcoms claim of continuing infringement, and the ITC had not ruled on the issue when the
appellate court reversed the original 983 infringement finding and remanded it to the ITC for
further proceedings. Both matters the enforcement action and
the original, remanded action
were still pending as of the date of settlement.
The 467 district court case, which coincided with the ITC matter, covered a different set of
Broadcom patents. The 467 jury returned a verdict of infringement in May 2007 (just before the
ITCs June exclusion order), with a damages verdict of just under $20 million
(growing to $25 million including post-judgment interest).1 In August 2007, the district
court held an injunction hearing, deliberated for several months and issued its injunction
|
|
|
1 |
|
The damages award was reduced to $13 million in a
subsequent court ruling that found the 686 patent to be invalid. |
Mr. Larry Spirgel
August 14, 2009
Page 6
decision on December 31, 2007. The resulting order included an immediate permanent
injunction as to certain products and, as to other products, a mandatory royalty which, on January
31, 2009, would convert to a permanent injunction.
In anticipation of an injunction order, the Company had engaged in extensive efforts, working
closely with handset manufacturers and carriers, to develop, test and implement design arounds for
each of the three patents at issue in the 467 trial. [***] By January 31, 2009, the end of the royalty bearing period, the Company had
developed and deployed design arounds for all three patents. [***]
Following the permanent injunction in the 467 case, Broadcom brought a series of contempt motions
against the Company. Although the Company believed that each of the contempt motions was meritless,
the district court repeatedly found the Company in contempt based on disagreements over the
interpretation of the courts injunction order. In its last contempt ruling before the settlement,
the district court found the Company in contempt for pursuing admittedly noninfringing activities.
The result was a de facto and, in the Companys view, unlawful broadening of the scope of the
injunction beyond the scope of the underlying patents at issue. The successive and increasingly
unpredictable contempt rulings by the district court increased uncertainty and contributed to the
burdens associated with the Companys compliance program under the injunction. This in turn
increased the risks, uncertainties and burdens on the Companys customers and the downstream
carriers affected by the injunction.
As this state of affairs continued, [***].
Having failed to persuade the district court that its recent interpretation of the injunction order
was improper and unlawful, the Company appealed the contempt rulings and sought expedited review,
in order to bring the injunction back within its proper scope. On January 30, 2009, two days after
the Company filed its Form 10-Q for the quarterly period ended December 28, 2008, the Federal
Circuit denied the Companys request for an expedited appeal. That meant it would be several months
before the Federal Circuit would schedule oral argument on the appeal, let alone issue a decision,
and the district courts erroneous interpretation of its injunction order and the procedures by
which a contempt motion may be adjudged could continue without correction.
At the time the Federal Circuit rejected the request for expedited treatment, Broadcom had filed
another motion for contempt challenging the Companys design arounds to one of the patents-in-suit.
In the Risk Factors section of its Form 10-Q for the quarterly period ended December 28, 2008, the
Company explained that a negative outcome in any such litigation could severely disrupt the
business of our chipset customers and their wireless carriers, which in turn could hurt our
relationships with our chipset customers and wireless
Mr. Larry Spirgel
August 14, 2009
Page 7
operators and could result in a decline in our share of worldwide chipset sales and/or a reduction in our licensees sales to wireless
operators, causing a corresponding decline in our chipset and/or licensing revenues. Although the
Company was confident that its design arounds successfully avoided infringement, an incorrect
decision by the district court on this issue, even if corrected on
appeal, [***].
In addition to the various contempt motions, the Company was still defending the assertion of
another patent in the same 467 case, which had not been involved in the earlier trial. The
litigation of issues relating to the 051 patent had previously been stayed pending the outcome of
the USPTOs reexamination of the validity of that patent. The 051 patent came out of reexamination
in late 2008, with many claims abandoned but many others newly added. The district court set trial
to begin in September 2009. The Company accumulated significant evidence demonstrating the
invalidity of the remaining claims of the 051 patent. Indeed, after the settlement, on June 23,
2009, the USPTO rejected all of the 051 patent claims that had formed the basis for Broadcoms
infringement case. Nevertheless, at the time of the settlement, the Company faced another jury
trial and potential injunction hearing in front of the same court that had issued the prior
injunction order and contempt decisions. After four years of litigation, an ITC exclusion order and
a cease and desist order, an injunction order, overly broad applications of the injunction order to
find the Company in contempt, and numerous design around efforts, the prospect of another
potentially adverse result was a significant concern, [***] even if the Company proceeded to trial and
successfully defended the 051 patent claim (by, for example, demonstrating its invalidity as had
been demonstrated to the USPTO in the reexamination process).
The 467 district court had also stayed the separate infringement action (the 468 case) brought by
Broadcom because the patents at issue were already being litigated in the ITC proceeding. The 468
stay would have been lifted after the ITC case came to a final conclusion with no further appeals.
Once that occurred, Broadcom would have had an opportunity to re-litigate the patents in the
district court, even the patents on which it lost, because ITC decisions regarding infringement and
validity do not have binding legal effect in district court.
It is important to note that the patent litigation described above was not the only litigation with
Broadcom that had occurred or that was still pending as of the date of the settlement. Among the
several actions still pending was the antitrust suit first filed on July 1, 2005 and subsequently
transferred to the Southern District of California. Because of the wide-ranging nature of the
allegations, the Company was forced to undertake an extremely burdensome and expensive document
review and production process involving more than
Mr. Larry Spirgel
August 14, 2009
Page 8
[***] pages. The allegations, while meritless in
the Companys view, challenged certain of the Companys business practices and posed additional
risks.
The Companys decision to settle these matters was based on an evaluation of the entire spectrum of
litigation listed and described above, consideration of the ongoing risks and uncertainties raised
by the various developments in the litigation and the burden upon the Company [***]. Ultimately, the resolution reflected the Companys
determination that resolving the litigation, on the terms set forth in the agreement, would
increase shareholder value, more than would be the case if the Company were to pursue a successful
resolution of these matters through the courts over the next several years.
Responses to Comments
The numbered paragraphs below restate the numbered paragraphs in the Staffs letter, and the
discussion set out below each paragraph is the Companys response to the Staffs comment.
1. |
|
Please provide us a comprehensive analysis of each key provision of the Settlement and Patent
License and Non-Assert Agreement (the Agreement) Qualcomm entered into with Broadcom, and
provide us a copy of it. As part of your response, describe for us the certain rights Broadcom
and Qualcomm have granted to each other under their respective patent portfolios. |
Response to comment #1:
The Agreement has been submitted supplementally as Confidential Material to this response.
The key provisions of the Agreement can be summarized as follows:
|
a) |
|
Broadcom agrees to terminate (with prejudice) all of its litigation with Qualcomm,
including (a) patent infringement claims in the International Trade Commission; (b) two
cases alleging patent infringement in the United States District Court for the Central
District of California; (c) antitrust and declaratory relief actions in the United States
District Court for the Southern District of California; (d) Broadcoms antitrust complaint
to the European Commission; and (e) Broadcoms antitrust complaint to the Korea Fair Trade
Commission. Broadcom and Qualcomm also grant releases to each other with respect to other
existing claims. (Recital para. A, Sections 4 & 5, Attachment D.) |
Mr. Larry Spirgel
August 14, 2009
Page 9
|
b) |
|
Qualcomm agrees to pay Broadcom a total of $891.2 million in the form of an initial
payment of $200 million (less certain possible deductions) and sixteen quarterly payments
of $43.2 million each. (Section 3.) |
|
|
c) |
|
Broadcom and Qualcomm agree not to assert patents having a priority date before April
27, 2013 against each other for certain of their respective integrated circuit products
and certain other products and services. In addition, Broadcom and Qualcomm agree not to
assert additional potential patent infringement claims against each other for a period of
four years. (Section 6.) |
|
|
d) |
|
Broadcom agrees not to assert its patents having a priority date before April 27,
2010 against Qualcomms customers for Qualcomms integrated circuit products incorporated
into cellular products. Subject to other provisions in the Agreement, Qualcomms customers
do not, however, receive rights to any of Broadcoms patents with respect to Qualcomm
integrated circuit products incorporated into non-cellular products and equipment.
(Sections 7.1, 7.9.) |
|
|
e) |
|
Qualcomm agrees not to assert its patents having a priority date before April 27,
2010 against Broadcoms customers for Broadcoms integrated circuit products incorporated
in non-cellular products. Broadcom customers do not, however, receive rights to any of
Qualcomms patents with respect to Broadcom integrated circuit products incorporated into
cellular products and equipment. (Sections 7.2, 7.9.) |
|
|
f) |
|
Broadcom grants Qualcomm an exhaustive license to certain patents that were the
subject of litigation between the parties, and to portions of related patents, for
integrated circuit and software products. (Section 7.3.) |
|
|
g) |
|
Broadcom agrees to assign certain patents to Qualcomm. (Section 8.) |
2. |
|
Please explain to us how you determined the fair value of the assets to be received pursuant
to the Agreement is $38 million, and provide us a copy of any valuation report that was
prepared in connection with the determination. |
|
|
|
Response: |
|
|
|
Please see the consolidated response following comment #4. |
3. |
|
We note that Qualcomm allocated only $38 million of the Agreement value to the assets
received. Please provide us a discussion that addresses why this allocation is reasonable and
is consistent with the way Qualcomm will utilize the rights granted to it under Broadcoms
patent portfolio. |
|
|
|
Response: |
Mr. Larry Spirgel
August 14, 2009
Page 10
|
|
Please see the consolidated response following comment #4. |
4. |
|
Based upon your disclosure it appears that you have utilized a residual methodology to
allocate $748 million to the litigation settlement charge in the second quarter of fiscal
2009. Please explain to us in detail why you were not able to separately value, or chose not
to separately value, the litigation settlement charge. As part of your response, please
explain to us in detail how you considered, or why you did not consider, the $25 million final
judgment in the 467 case in valuing the open litigation between Qualcomm and Broadcom. It
appears that this final judgment is objective evidence that could be used to value part of the
litigation settlement component of the Agreement. Other objective evidence that could be used
to value the litigation settlement component would appear to be the application of a royalty
rate to revenue attributable to products that utilize, or allegedly utilize, patents at the
center of Qualcomms litigation with Broadcom. Please explain to us how you have considered
this historical evidence in valuing the components of the Agreement, and provide us a schedule
of revenue by relevant product and patent for applicable periods as part of your response. |
Response to comments #2, #3 and #4:
The Company is providing a consolidated response to comments #2, #3 and #4 due to their overlapping
subject matter. The valuation report prepared by Duff & Phelps2 has been submitted
supplementally as Confidential Material to this response.
The Company evaluated the following key benefits received under or resulting from the Agreement:
|
|
|
Assigned Patents |
|
|
|
|
Patents-In-Suit |
|
|
|
|
Covenant Not to Assert by Broadcom |
|
|
|
|
Standstill Agreement |
|
|
|
|
Avoided Future Litigation Expenses |
|
|
|
|
Avoided Future Customer Disruption |
Benefits for Which the Company Recorded Assets
The fair values of the assigned patents and the patents-in-suit were estimated by the Company, and
reflected in the balance sheet, as follows:
|
|
|
2 |
|
The amounts recorded in the Companys Form 10-Q for the
quarterly period ended March 29, 2009 considered Duff & Phelps draft report,
which was finalized on June 22, 2009. |
Mr. Larry Spirgel
August 14, 2009
Page 11
|
|
|
|
Assigned patents
|
|
$11.0 |
million |
Patents-in-suit:
|
|
|
|
317
|
|
25.0 |
|
051
|
|
0.7 |
|
311
|
|
0.7 |
|
010,
983, 675
|
|
0.4 |
|
|
|
|
|
Patents-in-suit subtotal
|
|
27.0 |
|
Total
|
|
$38.0 |
million |
|
|
|
|
Assigned Patents
The assigned patents represent 50 patent families (consisting of 90 granted U.S. patents and 111
total patents) transferred to the Company by Broadcom that were not related to any of Broadcoms
infringement allegations. [***]
Obtaining patents was not a primary goal in the Companys negotiations with Broadcom; their receipt
was an ancillary result. The assigned patents may be useful [***]. However, this value is
buyer-specific and is not probable or reasonably estimable.
The assigned patents could have offensive value to a market participant because the market
participant could attempt to license these assigned patents or assert them against certain
companies in the industry. Thus, from a market participant perspective, the assigned patents do
have probable economic benefit to the Company, as the Company could sell the assigned patents to a
market participant. Because the value of these patents is based on selling them to a market
participant, the most reliable and market participant-based framework to estimate the fair value
was to use market comparable patent transaction data, which indicates what third parties are
willing to pay for patents that could be exploited in an offensive licensing program.
In estimating the fair value of the assigned patents, various patent transaction prices were
considered, including patent transaction prices from the Companys own past transactions and from
publicly available sources. Using that data, the Company determined a median value per patent
family and a weighted-average price per U.S. patent and then calculated a range for the fair value
of the assigned patents of $11 million (using the per patent family data) to $14 million (using the
per patent data). The Company chose to rely on the $11 million end of the range because the Company
had analyzed and selected the patents on a per family basis, not on an individual patent basis.
Patents-in-Suit
The license to the patents-in-suit does not represent patent ownership; it only represents an
exhaustive license to the seven patents as well as to certain claims of related patents in the
Agreement. The Company does not have the right to assert the patents-in-suit in future negotiations
with third parties. Thus, the only value of the license to the patents-in-suit (if any) would come
from use of those patents in existing or planned future Company products. Of the seven
patents-in-suit, the Company determined that the license rights
Mr. Larry Spirgel
August 14, 2009
Page 12
related to six of the seven patents represent assets with values that could be reasonably
estimated. The remaining patent license (related to the 686 patent) has no value because the
relevant claim of the patent was determined to be invalid by the Federal Circuit.
For the
317 patent license, the most reliable method of valuation was a cost savings method,
because while the Company was not using the patent at the time of the settlement and had developed
technology that designed around the patent, the Company planned to use the patented technology in
the future. In order to value this patent license, the Company estimated the projected cost savings
to the Company by not using its design around technology for the remainder of the patent life and
using the patent instead. The projected cost savings were tax affected and discounted back to
present value, and then the tax savings of amortization were added, to arrive at the estimated fair
value of the patent of $25 million.
For the license to the other five patents-in-suit, the Company either did not plan to stop using
the applicable design around or believed that the Companys existing and planned future products do
not and will not use the patented technology. As such, the Company looked to the perspective of a
market participant. Because the Company concluded that the value to a market participant under a
licensing or decision tree framework would have been highly speculative and that transaction data
would serve as an indication as to the amount a market participant would be willing to pay for
similar patents, the Company used a market comparables approach. Accordingly, various patent
transaction prices were considered, as described above. From that data, the Company relied upon
either the weighted-average price per U.S. patent or the top decile of the average price per U.S.
patent. Although the value of an owned patent should, in theory, exceed the value of a license to
that patent, the Company concluded that this approach would provide a reliable proxy for the
license value for this purpose.
Benefits for Which the Company Did Not Record Assets
Other elements of value to the Company resulting from the Agreement included (a) the covenant not
to assert and standstill agreement, (b) avoided future litigation expenses, and (c) avoided future
customer disruption. The Company concluded that these benefits do not meet the definition of an
asset in CON 6 because they do not embody probable future economic benefits that involve a capacity
to contribute to future net cash inflows nor are such benefits exchangeable or, with respect to (b)
and (c) above, legally enforceable. In addition, the Company did not have a reasonable basis on
which to estimate the value of these items. Accordingly, the residual amount was allocated to these
elements and was recognized immediately as litigation settlement expense in the statement of
operations.
Covenant Not To Assert and Standstill Agreement
The Company concluded that no value should be assigned to Broadcoms covenant not to assert and
standstill agreement because these cross-covenants were considered to be protective measures taken
by the companies to avoid future litigation. This is contrasted
Mr. Larry Spirgel
August 14, 2009
Page 13
with the assignment of value to the license to the patents-in-suit where such patents had been
asserted against the Company by Broadcom. Given the breadth of Broadcoms legal assault and
infringement assertions against the Company, it was considered reasonable to conclude that, if
there were other Broadcom patents that Broadcom believed the Company was infringing, Broadcom would
have asserted those as well. Broadcoms failure to do so is consistent with the Companys
conclusion that no value should be ascribed to Broadcoms covenant not to assert. In reaching the
conclusion on the covenant not to assert and the standstill agreement, the Company also considered
remarks made by Eric C. West, Associate Chief Accountant, Office of the Chief Accountant at the SEC
before the 2007 AICPA National Conference on Current SEC and PCAOB Developments on December 10,
2007. In his speech, Mr. West indicated that general covenants not to sue may not meet the
definition of an asset or have value to a market participant.
Avoided Future Litigation Expenses
In the Companys view, avoided future litigation expenses were a significant component of the
settlement. Over the last few years, the Company has incurred significant litigation expenses
related to Broadcom matters [***]. With respect to the value of avoided future litigation expenses,
the Company was not able to estimate the amount that would have been incurred in the future due to
the Broadcom matters with sufficient reliability for accounting purposes as litigation expenses can
be unpredictable in probability, timing and amount. However, it is reasonable to assume that the
Company could have incurred [***] dollars in future litigation expenses had the
Agreement not been reached. A key component of settling this matter was to mitigate the uncertainty
associated with the probability, timing and amount of future payments for litigation.
Avoided Future Customer Disruption
The Company was willing to pay Broadcom an amount in excess of the estimated fair value of the
assigned patents and other intangible rights received because of the anticipated future benefit
associated with avoiding [***].
[***]
The Residual Method of Accounting
As noted above, the Company concluded that the principal benefits derived from the Agreement were
avoided future litigation expenses and [***]. The Company could not reliably estimate their fair
values for accounting purposes and concluded that such benefits did not meet the definition of an
asset. Accordingly, the residual approach to allocating the amount paid to Broadcom to the
individual elements in the arrangement was deemed to be appropriate and was applied as follows:
Mr. Larry Spirgel
August 14, 2009
Page 14
|
|
|
|
|
(in millions) |
|
|
|
|
Gross obligation |
|
$ |
891 |
|
|
|
|
|
|
Fair value of assets received |
|
|
(38 |
) |
|
|
|
|
|
Discount on long-term obligation
(imputed interest pursuant to APB 21) |
|
|
(45 |
) |
|
|
|
|
|
Accrued liabilities to Broadcom
(expensed in prior periods) |
|
|
(60 |
) |
|
|
|
|
Total settlement charge in Q2FY09 |
|
$ |
748 |
|
|
|
|
|
In deciding on this approach, the Company considered remarks made by Eric C. West, Associate Chief
Accountant, Office of the Chief Accountant at the SEC before the 2007 AICPA National Conference on
Current SEC and PCAOB Developments on December 10, 2007. In his speech, Mr. West indicated that if
an individual element cannot be valued in accounting for litigation settlements, a residual
approach may be appropriate.
The accrued liabilities to Broadcom represented the unpaid portion of amounts that had been accrued
and recorded for the damages award and for deemed royalties as a result of the compulsory license
awarded by the court. The deemed royalties were classified as cost of sales starting in fiscal
2008. The court in the 467 case issued an award that was subsequently revised to approximately $13
million (including $1.3 million in pre-judgment interest). In addition to the damages award, the
Company accrued (and reported) approximately [***] for deemed royalties owed to Broadcom pursuant
to the order related to sales by the Company from the original verdict date of May 29, 2007 through
December 28, 2008 (the fiscal quarter end preceding the fiscal quarter in which the settlement was
recorded). Such amounts were based on the compulsory license methodologies set by the court, which
were frequently modified and reinterpreted by the court in subsequent legal proceedings. The deemed
royalties [***] as discussed in response to comment #6
below. The court also imposed various remedies related to the permanent injunction. The Companys
final report to Broadcom was provided on February 20, 2009 as the mandatory royalty converted to a
permanent injunction on January 31, 2009. The Company did not anticipate reporting or paying any additional amounts to
Broadcom pursuant to the judgment as a result of design arounds and changes in its business
practices such that its products would not be in violation of any Broadcom patent at issue in the
467 case. As such, there would be no future activity on which to base a royalty.
I refer the Staff to the Companys response to comment #5 below regarding the relevance of the
damages award in the 467 case to the value of the full spectrum of pending litigation.
5. |
|
We note that Qualcomm allocated $748 million of the Agreement value to the litigation
settlement charge. Please provide us a comprehensive discussion that addresses why $748
million is reasonable in light of each open law suit, patent infringement claim, etc.,
as discussed in Item 3 and Note 8 of Qualcomms 2008 Form 10-K and Note 7 of Qualcomms first
quarter Form 10-Q. Based upon our review of these disclosures, |
Mr. Larry Spirgel
August 14, 2009
Page 15
|
|
there appears to be no correlation between the sizable settlement amount and (i) the limited
disclosure in Qualcomms filings as to each open lawsuit, etc., and (ii) the $25 million final
judgment in the 467 case. For example, there appears to have been little progress since the July 1,
2005 and October 7, 2008 actions filed by Broadcom, including no discovery by the parties, and very
limited disclosure in the filings regarding these two actions, for these two items to comprise any
significant portion of a $748 million litigation settlement. As another example, there is no
indication from your disclosure that the three patent claims at hand in the ITC hearing that
commenced on February 14, 2006 could comprise any significant portion of a $748 million litigation
settlement. In this regard, disclosure states that Qualcomm did not infringe on seven out of the
eight products at issue on the 675 patent and it did not
directly infringe on the 983 patent. In
regard to the 467 case, it is not clear why the settlement amount for open patent claims would be
disproportionate to the final judgment in the 467 case. In summary, we believe your limited
disclosure is a strong indication that the litigation settlement component of the Agreement is not
substantial. |
Response to comment #5:
The Companys decision to allocate $748 million of the Agreement value to the litigation settlement
was reasonable, based on an evaluation of the entire spectrum of pending litigation with Broadcom
and the valuation of the assets obtained pursuant to the Agreement. I refer to the Companys
response to comments #2, #3 and #4 regarding how the $748 million litigation settlement charge was
determined and the Overview.
For the
reasons discussed below, the Company concluded that there was no
direct correlation between the
settlement amount and the $25 million final judgment in the 467 case, which was subsequently
reduced to $13 million (the damages award). The jury trial that led to the damages award in the
467 case was just one aspect of a broader set of issues in the 467 case, and the 467 case was just
one of a number of pending cases between the Company and Broadcom. There were other pending patent
claims (e.g., the 051 patent and the 468 case) as well as non-patent cases (e.g., the antitrust
suit).
The
damages award that followed the May 2007 jury verdict has no
direct correlation to or bearing on the
ultimate settlement amount. That damages award was calculated based on patent law principles, by
applying a reasonable royalty rate to certain sales during the relevant period (in this case, a
limited timeframe of approximately two years). Using the damages award as a basis for valuing the
additional open litigation, which included patent and non-patent claims and posed the potential for
significant harm to the Companys business from injunctive relief, was not considered appropriate
for the following reasons:
|
a) |
|
The damages award represented damages solely for a few claims in one lawsuit that
related to a relatively small number of the Companys products over a limited timeframe. |
Mr. Larry Spirgel
August 14, 2009
Page 16
|
b) |
|
It did not take into account the significance of the injunctive relief in the 467
case or the potential injunctive relief in the remaining litigation. |
|
|
c) |
|
The claims underlying the damages award and the other open patent claims were too
dissimilar to consider the damages award as a benchmark. |
|
|
d) |
|
The other outstanding cases and the remaining patent dispute in the 467 case had not
yet reached a final judgment. |
|
|
e) |
|
Using the damages award to value the settlement would not have taken into account
[***]. |
|
|
f) |
|
It did not take into account the significant ongoing litigation costs. |
|
|
g) |
|
The Company did not consider the court-imposed rate to be a market-participant rate
because the rate was not developed through a market process and it included an element of
penalty for continued use during the compulsory license period. |
The settlement amount reflects the Companys assessment of the value of resolving the open
litigation claims and their associated risks, which were discussed in the Companys filings. As
noted in the Overview above, despite the Companys best efforts to comply, the district court had
twice found the Company in contempt of the permanent injunction in the 467 case, and a third
contempt motion was pending at the time of the settlement. [***] The Company was also actively defending against an antitrust suit (the July 1,
2005 action) that challenged certain of the Companys business practices and posed additional risks
for the Company, [***].
As the Company explained in its Form 10-Q for the quarterly period ended December 28, 2008, the
court in the 467 case had granted portions of two [contempt] motions and Broadcom ha[d] filed a
third contempt motion relating to the design around of the 317 patent. The Company further
explained that the [t]rial [of the 051 patent] is scheduled in September 2009. The Company also
stated that Broadcom had filed an antitrust action generally relating to licensing and chipset
sales activities, seeking monetary damages and injunctive relief. In its Form 10-Q for the
quarterly period ended December 28, 2008, the Company explained the risks from those litigations,
including the following:
|
|
|
If any of our products were found to infringe on another companys intellectual
property rights, we could be subject to an injunction or required to redesign our
products, which could be costly, or to license such rights and/or pay damages or other
compensation to such other company. |
|
|
|
|
A negative outcome in any such litigation could severely disrupt the business of our
chipset customers and their wireless customers, which in turn could hurt our relationships
with our chipset customers and wireless operators and could result in a decline in our
share of worldwide chipset sales and/or a reduction in our licensees |
Mr. Larry Spirgel
August 14, 2009
Page 17
sales to wireless operators, causing a corresponding decline in our chipset and/or
licensing revenues.
As discussed in the Overview above, a key development in the Companys assessment of the timing and
value of the settlement was the Federal Circuits denial of the Companys request to hear its
appeals in the 467 case on an expedited schedule. With the denial of the motion to expedite, the
Company was concerned that its appeal contesting the district courts broad interpretation of the
injunction order would not be decided in time to prevent one or more additional contempt rulings by
the district court that would harm the Company and its customers. The denial of the request for
expedition, which occurred two days after the Company filed its Form 10-Q for the quarterly period
ended December 28, 2008, meant that it would be several months before the Federal Circuit would
even hear oral argument on the appeal, let alone issue a decision. In short, in the Companys view,
through successive contempt motions the district court was improperly applying an expansive reading
of the courts injunction order beyond the scope of the patents at issue in a manner that
threatened the Companys ongoing business, and yet, upon the denial of expedited appellate review,
the legal process did not afford timely relief to the Company.
The Company consistently provided disclosure with respect to the Broadcom litigation in the
footnotes to the financial statements, Legal Proceedings section, Managements Discussion and
Analysis and Risk Factors contained in its reports filed under the Exchange Act. The Company
believes that these disclosures allowed investors to understand and adequately assess the potential
risks associated with the litigation, as evidenced by the lack of adverse impact on the Companys
stock price following the announcement of the Agreement and comments from many of the analysts
covering the Company.
In summary, the driving force in the Companys decision to enter into the Agreement was the open
litigation, which was costing the Company a tremendous amount of money, was posing significant
risks to the business, [***] and was creating uncertainty for the Company, its customers and its
shareholders. The timing of the settlement was particularly influenced by the Federal Circuits
January 30, 2009 denial of the Companys request for an expedited schedule, which exposed the
Company to additional contempt rulings and the district courts continuing expansive reading of its
injunctive order without the opportunity for timely reversal, a particular concern given the
upcoming hearing on the design around relating to the Companys 3G CDMA chipsets. The Agreement
enabled the Company to put all of those burdens in the past and move forward. The Companys
decision to settle the litigation for $891.2 million reflected its determination that paying that
amount would increase shareholder value, more than would be the case if the Company were to pursue
a successful resolution of these matters through the courts over the next several years.
6. |
|
Please tell us more about the assistance you provide to your customers, as discussed in the
last bullet point. Explain to us what you mean by financial support to minimize the impact of
litigation in which (you) are involved. Also, tell us whether you provided any assistance,
including the nature and amount of the assistance, on behalf of any customers that was related to your litigation with Broadcom. Finally, tell us how you |
Mr. Larry Spirgel
August 14, 2009
Page 18
are accounting for any assistance provided to your customers and refer to your basis in the
accounting literature.
Response to comment #6:
There were two arrangements under which the Company provided financial support to customers to
minimize the impact of litigation in which the Company was involved,
[***].
In September 2007, the Company agreed to [***]. However, the Company entered into this agreement [***].
Separately, the Company was contingently liable under an agreement that was entered into [***]
arising from certain claims of patent infringement [***] related to products or services sold
or provided by the Company. Under this agreement, the Company was
also obligated to [***]. This [***] agreement was not initially measured and recognized at fair value
because it was deemed to be similar to a product warranty in that it related to claims and/or other
actions that could impair [***] ability to use the Companys products or services and therefore
qualified for the scope exception under FIN 45, paragraph 7(b). Accordingly, the Company recorded
contingent liabilities resulting from the arrangement when they were probable and could be
reasonably estimated in accordance with FAS 5.
Because the [***] agreements were
made to parties that are customers as defined by EITF 01-9, they were classified in the statement
of operations in accordance with this guidance. The Company determined that the amounts should be
classified as a reduction of revenue when recognized in the statement of operations because the
Company did not receive identifiable benefits in exchange for the cash consideration that were
sufficiently separable from the customers purchase of its products. The total amounts recognized
in earnings for these [***] to customers
were approximately [***] and [***], respectively, during the six months ended March 29, 2009 and
[***] and [***], respectively, for the year ended September 28, 2008.
Mr. Larry Spirgel
August 14, 2009
Page 19
In connection with its response to the Commission Staffs comments, the Company acknowledges that
(i) it is responsible for the adequacy and accuracy of the disclosure in the filings; (ii) Staff
comments or changes to disclosure in response to Staff comments in the filings reviewed by the
Staff do not foreclose the Commission from taking any action with respect to the filing; and (iii)
the Company may not assert Staff comments as a defense in any proceeding initiated by the
Commission or any person under the federal securities laws of the United States.
Please do not hesitate to contact me should you have additional questions.
Sincerely,
DLA Piper LLP (US)
|
|
|
|
|
|
|
|
By: |
/s/ Cameron Jay Rains |
|
|
|
Cameron Jay Rains |
|
|
Admitted to practice in California